• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Surgery for Laryngopharyngeal SCC in the Era of Organ Preservation.喉咽 SCC 的器官保存时代的手术治疗。
Clin Exp Otorhinolaryngol. 2009 Dec;2(4):159-63. doi: 10.3342/ceo.2009.2.4.159. Epub 2009 Dec 31.
2
Larynx preservation.喉保留
Curr Opin Oncol. 2012 May;24(3):218-22. doi: 10.1097/CCO.0b013e3283523c95.
3
[Pathomorphological aspects of transoral resection of hypopharyngeal carcinoma with preservation of the larynx. Patient selection, treatment results].[保留喉的下咽癌经口切除术的病理形态学方面。患者选择、治疗结果]
Laryngorhinootologie. 1999 Dec;78(12):654-62. doi: 10.1055/s-1999-8771.
4
Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).对于晚期喉癌和下咽癌,采用紫杉醇和顺铂进行诱导化疗,随后进行放疗以保留喉器官,其晚期毒性结果中等(DeLOS-I试验)。
Eur Arch Otorhinolaryngol. 2009 Aug;266(8):1291-300. doi: 10.1007/s00405-008-0846-y. Epub 2008 Oct 30.
5
Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.梨状窦癌的喉保留:欧洲癌症研究与治疗组织III期试验的初步结果。欧洲癌症研究与治疗组织头颈癌合作组
J Natl Cancer Inst. 1996 Jul 3;88(13):890-9. doi: 10.1093/jnci/88.13.890.
6
[Induction chemotherapy and larynx preservation: is such practice useful?].[诱导化疗与喉保留:这种做法有用吗?]
Bull Cancer. 2002 Apr;89(4):411-7.
7
Current status of larynx preservation trials.喉保留试验的现状
Curr Opin Oncol. 1996 May;8(3):209-14. doi: 10.1097/00001622-199605000-00007.
8
Which Larynx-Preservation Strategy Would Be Best for a Patient With Resectable, Locally Advanced, Hypopharynx Squamous Cell Carcinoma?对于可切除、局部晚期下咽鳞状细胞癌患者,哪种喉保留策略最佳?
Oncology (Williston Park). 2020 Jun 10;34(6):211-215.
9
[The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].[局部晚期喉癌和下咽癌器官保留治疗的结果及毒性]
Otolaryngol Pol. 2011 Sep-Oct;65(5):363-8. doi: 10.1016/S0030-6657(11)70727-2.
10
Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.顺铂、5-氟尿嘧啶、甲氨蝶呤和亚叶酸钙同步放化疗用于晚期可切除喉和下咽鳞状细胞癌患者
Acta Otolaryngol. 2006 Apr;126(4):408-13. doi: 10.1080/00016480500401019.

引用本文的文献

1
A novel surgical approach for hypopharyngeal carcinoma resection via the paraglottic space.一种经声门旁间隙切除下咽癌的新型手术方法。
BMC Surg. 2021 May 3;21(1):230. doi: 10.1186/s12893-021-01223-1.
2
Matched-Pair Analysis of Survival in the Patients with Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma Treated with Induction Chemotherapy Plus Chemo-Radiation or Total Laryngectomy.诱导化疗联合放化疗或全喉切除术治疗晚期喉和下咽鳞状细胞癌患者生存情况的配对分析
Cancers (Basel). 2021 Apr 6;13(7):1735. doi: 10.3390/cancers13071735.

本文引用的文献

1
Reexamining the treatment of advanced laryngeal cancer.重新审视晚期喉癌的治疗方法。
Head Neck. 2010 Jan;32(1):1-7. doi: 10.1002/hed.21294.
2
Current trends in initial management of laryngeal cancer: the declining use of open surgery.喉癌初始治疗的当前趋势:开放手术的使用减少
Eur Arch Otorhinolaryngol. 2009 Sep;266(9):1333-52. doi: 10.1007/s00405-009-1028-2. Epub 2009 Jul 14.
3
Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer.经口激光显微手术联合辅助放疗治疗局部晚期喉癌后的器官功能及生活质量
Strahlenther Onkol. 2009 May;185(5):303-9. doi: 10.1007/s00066-009-1967-y. Epub 2009 May 15.
4
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.顺铂和5-氟尿嘧啶联合或不联合多西他赛进行诱导化疗以保留喉功能的随机试验。
J Natl Cancer Inst. 2009 Apr 1;101(7):498-506. doi: 10.1093/jnci/djp007. Epub 2009 Mar 24.
5
Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.喉保留临床试验设计:关键问题与建议——共识小组总结
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1293-303. doi: 10.1016/j.ijrobp.2008.10.047.
6
Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.喉保留临床试验设计:关键问题与建议——共识小组总结
Head Neck. 2009 Apr;31(4):429-41. doi: 10.1002/hed.21081.
7
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.TAX 324研究中局部晚期喉癌和下咽癌亚组的序贯治疗:生存、手术及器官保留情况
Ann Oncol. 2009 May;20(5):921-7. doi: 10.1093/annonc/mdn752. Epub 2009 Jan 29.
8
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.关于喉保留的3期随机试验:序贯化疗与放疗对比交替化疗与放疗。
J Natl Cancer Inst. 2009 Feb 4;101(3):142-52. doi: 10.1093/jnci/djn460. Epub 2009 Jan 27.
9
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.局部晚期头颈癌同步放化疗后严重晚期毒性反应的相关因素:一项美国放射肿瘤学组(RTOG)分析
J Clin Oncol. 2008 Jul 20;26(21):3582-9. doi: 10.1200/JCO.2007.14.8841. Epub 2008 Jun 16.
10
Supracricoid partial laryngectomy: an alternative to total laryngectomy for locally advanced laryngeal cancers.环状软骨上部分喉切除术:局部晚期喉癌全喉切除术的替代方案。
J Laryngol Otol. 2008 Nov;122(11):1219-23. doi: 10.1017/S0022215108001862. Epub 2008 Jun 6.

喉咽 SCC 的器官保存时代的手术治疗。

Surgery for Laryngopharyngeal SCC in the Era of Organ Preservation.

机构信息

Department of Head and Neck, Centre Oscar Lambret, Lille, France.

出版信息

Clin Exp Otorhinolaryngol. 2009 Dec;2(4):159-63. doi: 10.3342/ceo.2009.2.4.159. Epub 2009 Dec 31.

DOI:10.3342/ceo.2009.2.4.159
PMID:20072688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2804089/
Abstract

Over the past decades, randomized clinical trials have assessed and validated the concept of larynx preservation. This new concept has obviously modified the treatment algorithm for laryngopharyngeal squamous cell carcinoma. However surgery for larynx and hypopharynx cancer remains indicated in many cases. Initial partial surgery is indicated for early diseases. This surgery may be performed endoscopically or openly. The results are excellent in terms of local control and function. Transoral robotic surgery is under evaluation. Initial radical surgery is indicated for advanced diseases in case of very infiltrative tumor, in case of cartilage destruction or when tolerance and/or compliance to chemotherapy-based approached is questionable. Larynx preservation is to be discussed between these two situations. In randomized trials evaluating the different larynx preservation strategies, a substantial number of larynxes could be preserved without compromising disease control or survival. The best approach in terms of quality of function preservation, overall acute and late toxicity, disease control and survival is still a matter of clinical research. It must be stressed that salvage surgery is a definite part of these larynx preservation protocols in order to maintain the ultimate disease control. This discussion underscored the need of a multidisciplinary decision making and the need of a coordinated clinical research.

摘要

在过去的几十年中,随机临床试验评估和验证了保留喉的概念。这一新概念显然改变了喉咽鳞状细胞癌的治疗方案。然而,在许多情况下,仍需要进行喉和下咽癌的手术。早期疾病的初始部分手术是指征。这种手术可以通过内镜或开放性进行。局部控制和功能方面的结果非常出色。经口机器人手术正在评估中。对于非常浸润性肿瘤、软骨破坏或对基于化疗的方法的耐受性和/或依从性存在疑问的情况下,应考虑进行初始根治性手术。在这两种情况下,都需要讨论保留喉的问题。在评估不同的保留喉策略的随机试验中,大量的喉可以保留而不会影响疾病控制或生存率。在功能保留质量、整体急性和晚期毒性、疾病控制和生存率方面,最佳方法仍然是临床研究的问题。必须强调的是,挽救性手术是这些保留喉方案的一个重要组成部分,以维持最终的疾病控制。这种讨论强调了多学科决策的必要性和协调临床研究的必要性。